Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,639
Total Claims
$1.3M
Drug Cost
449
Beneficiaries
$3,004
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-92%
Opioid rate vs peers
0.2% vs 2.2% avg
+113%
Cost per patient vs peers
$3,004 vs $1,411 avg
+71%
Brand preference vs peers
18.1% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
19
Opioid Claims
$20
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,844 claims · $1.2M
Generic: 8,316 claims · $168K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 124 | $161K |
| Sitagliptin Phos/Metformin Hcl | 117 | $142K |
| Sitagliptin Phosphate | 85 | $130K |
| Budesonide/Formoterol Fumarate | 182 | $86K |
| Apixaban | 61 | $68K |
| Semaglutide | 64 | $66K |
| Dulaglutide | 58 | $60K |
| Fluticasone/Umeclidin/Vilanter | 39 | $41K |
| Diclofenac Sodium | 608 | $35K |
| Insulin Glargine,hum.Rec.Anlog | 111 | $30K |
| Dapagliflozin Propanediol | 30 | $28K |
| Linagliptin | 19 | $27K |
| Fluticasone Propionate | 87 | $26K |
| Metformin Hcl | 13 | $22K |
| Semaglutide | 12 | $20K |
Prescribing Profile
Patient Profile
72
Avg Age
69%
Female
1.22
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data